• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳房重建中组织扩张器的感染性损失:我们是否在治疗正确的病原体?

Infectious Loss of Tissue Expanders in Breast Reconstruction: Are We Treating the Right Organisms?

作者信息

Klein Gabriel M, Phillips Brett T, Dagum Alexander B, Bui Duc T, Khan Sami U

机构信息

From the *Division of Plastic Surgery, Department of Surgery Stony Brook University Medical Center, Stony Brook, NY; and †Division of Plastic, Maxillofacial, and Oral Surgery, Department of Surgery Duke Medicine, Durham, NC.

出版信息

Ann Plast Surg. 2017 Feb;78(2):149-152. doi: 10.1097/SAP.0000000000000847.

DOI:10.1097/SAP.0000000000000847
PMID:28079697
Abstract

BACKGROUND

Postoperative infections following tissue expander-based breast reconstruction represent a significant threat to the reconstructive process. Studies have found the incidence to be as high as 29%. There has been abundant research into the risk factors associated with these infections, although very few studies have focused on the causative organisms. The purpose of this study was to investigate the bacterial flora associated with tissue expander infections after breast reconstruction.

METHODS

A retrospective analysis of all patients who underwent tissue expander-based breast reconstruction at our institution between February 2010 and April 2013 was conducted. The medical records were reviewed for demographic information, medical history, operative technique, postoperative course, and culture results. Descriptive data analysis was then performed.

RESULTS

A total of 56 tissue expander infections were identified in 49 patients during the study period. 41.1% of the cultures grew gram-positive organisms, whereas 28.6% grew gram-negative species. The 2 most common organisms were Staphylococcus aureus (17.9%) and Staphylococcus epidermidis (14.3%). Pseudomonas aeruginosa was the most frequent gram-negative species and was also the third most frequent organism cultured (10.9%).

DISCUSSION

Due to the high rate of infection in breast reconstruction patients, adequate perioperative prophylaxis is necessary. The surgeon must also be prepared to treat patients who may return with infection postoperatively. Although the majority of our infections were secondary to normal skin flora, a significant proportion were caused by gram-negative species. Given these results, the empiric antibiotic of choice for postoperative infections should be reconsidered to cover for these various organisms.

摘要

背景

基于组织扩张器的乳房重建术后感染对重建过程构成重大威胁。研究发现其发生率高达29%。虽然对与这些感染相关的危险因素已有大量研究,但很少有研究关注致病微生物。本研究的目的是调查乳房重建后与组织扩张器感染相关的细菌菌群。

方法

对2010年2月至2013年4月在我院接受基于组织扩张器的乳房重建的所有患者进行回顾性分析。查阅病历以获取人口统计学信息、病史、手术技术、术后病程及培养结果。然后进行描述性数据分析。

结果

在研究期间,49例患者中共发现56例组织扩张器感染。41.1%的培养物中生长出革兰氏阳性菌,而28.6%生长出革兰氏阴性菌。两种最常见的细菌是金黄色葡萄球菌(17.9%)和表皮葡萄球菌(14.3%)。铜绿假单胞菌是最常见的革兰氏阴性菌,也是培养出的第三常见细菌(10.9%)。

讨论

由于乳房重建患者的感染率较高,围手术期进行充分的预防是必要的。外科医生还必须准备好治疗术后可能因感染而复诊的患者。虽然我们的大多数感染继发于正常皮肤菌群,但相当一部分是由革兰氏阴性菌引起的。鉴于这些结果,应重新考虑术后感染经验性抗生素的选择,以覆盖这些不同的微生物。

相似文献

1
Infectious Loss of Tissue Expanders in Breast Reconstruction: Are We Treating the Right Organisms?乳房重建中组织扩张器的感染性损失:我们是否在治疗正确的病原体?
Ann Plast Surg. 2017 Feb;78(2):149-152. doi: 10.1097/SAP.0000000000000847.
2
Antibiogram for Periprosthetic Infections: A Tool for Better Informed Selection of Empiric Antibiotics for Surgical Site Infections.人工关节周围感染的抗菌谱:一种为手术部位感染更明智地选择经验性抗生素的工具。
Ann Plast Surg. 2016 May;76 Suppl 3:S158-61. doi: 10.1097/SAP.0000000000000803.
3
Antibiotic Prophylaxis and Resistance in Surgical Site Infection After Immediate Tissue Expander Reconstruction of the Breast.乳房即刻组织扩张器重建术后手术部位感染的抗生素预防与耐药性
Ann Plast Surg. 2016 Nov;77(5):501-505. doi: 10.1097/SAP.0000000000000275.
4
Double-Chamber Tissue Expanders Optimize Lower Pole Expansion in Immediate Breast Reconstruction Requiring Adjuvant Radiation Therapy.双腔组织扩张器可优化即刻乳房重建中需要辅助放疗的下极扩张效果。
Ann Plast Surg. 2016 May;76 Suppl 3:S171-4. doi: 10.1097/SAP.0000000000000768.
5
Antibiotic selection for the treatment of infectious complications of implant-based breast reconstruction.用于治疗植入物乳房重建术后感染并发症的抗生素选择。
Ann Plast Surg. 2013 Aug;71(2):140-3. doi: 10.1097/SAP.0b013e3182590924.
6
Long-term reconstructive outcomes after expander-implant breast reconstruction with serious infectious or wound-healing complications.扩张器-植入物乳房重建术后出现严重感染或伤口愈合并发症的长期重建效果。
Ann Plast Surg. 2012 Apr;68(4):369-73. doi: 10.1097/SAP.0b013e31823aee67.
7
One-Step Salvage of Infected Prosthetic Breast Reconstructions Using Antibiotic-Impregnated Polymethylmethacrylate Plates and Concurrent Tissue Expander Exchange.使用含抗生素的聚甲基丙烯酸甲酯板一步挽救感染的乳房假体再造并同期更换组织扩张器
Ann Plast Surg. 2016 Sep;77(3):280-5. doi: 10.1097/SAP.0000000000000409.
8
Role of bacterial biofilms in patients after reconstructive and aesthetic breast implant surgery.细菌生物膜在乳房重建及美容隆胸手术后患者中的作用。
J Long Term Eff Med Implants. 2014;24(2-3):131-8. doi: 10.1615/jlongtermeffmedimplants.2014011206.
9
Comparison of Reconstructive Outcomes in Breast Cancer Patients With Preexisting Subpectoral Implants: Implant-Sparing Mastectomy With Delayed Implant Exchange Versus Immediate Tissue Expander Reconstruction.乳腺癌患者术前已植入胸大肌下假体的重建效果比较:保留假体的乳房切除术并延迟更换假体与即刻组织扩张器重建术的比较。
Ann Plast Surg. 2016 Jun;76 Suppl 4:S332-5. doi: 10.1097/SAP.0000000000000751.
10
Expander/Implant Removal After Breast Reconstruction: Analysis of Risk Factors and Timeline.乳房重建后扩张器/植入物取出:危险因素及时间线分析
Aesthetic Plast Surg. 2018 Feb;42(1):64-72. doi: 10.1007/s00266-017-1031-8. Epub 2017 Dec 21.

引用本文的文献

1
Closed Expander Salvage With Dual-port Tissue Expander in Implant-based Breast Reconstruction for High Body Mass Index and Ptotic Patients.在基于植入物的乳房重建中,针对高体重指数和乳房下垂患者使用双端口组织扩张器进行闭合式扩张器挽救治疗
Plast Reconstr Surg Glob Open. 2025 Jun 16;13(6):e6845. doi: 10.1097/GOX.0000000000006845. eCollection 2025 Jun.
2
Risk Factors for Tissue Expander-Related Infections in Pediatric Scar Reconstruction: A 10-Year Retrospective Study.小儿瘢痕重建中组织扩张器相关感染的危险因素:一项 10 年回顾性研究。
Plast Reconstr Surg. 2024 Dec 1;154(6):1200e-1208e. doi: 10.1097/PRS.0000000000011390. Epub 2024 Mar 5.
3
Minimally Invasive and Innovative Management of Prosthesis Infections in Endoscopic-Assisted Breast Reconstruction.
内镜辅助乳房重建中假体感染的微创与创新处理。
Aesthetic Plast Surg. 2024 Feb;48(3):266-272. doi: 10.1007/s00266-023-03525-6. Epub 2023 Aug 21.
4
The risk factors and the relationship between radiation dose and complications and prosthetic reconstruction failure in patients with post-mastectomy breast implant reconstruction: a retrospective cohort study.乳房切除术后乳房植入物重建患者的危险因素以及辐射剂量与并发症和假体重建失败之间的关系:一项回顾性队列研究。
Gland Surg. 2022 Nov;11(11):1817-1831. doi: 10.21037/gs-22-633.
5
Staphylococcus aureus Breast Implant Infection Isolates Display Recalcitrance To Antibiotic Pocket Irrigants.金黄色葡萄球菌乳房植入物感染分离株对抗生素口袋灌洗液表现出耐药性。
Microbiol Spectr. 2023 Feb 14;11(1):e0288422. doi: 10.1128/spectrum.02884-22. Epub 2022 Dec 12.
6
Tissue Expander-Based Breast Reconstruction at a Major Safety-Net Hospital: Managing the Outsized Risk of Infection.在一家大型安全网医院进行的基于组织扩张器的乳房重建:应对感染的巨大风险
Aesthet Surg J Open Forum. 2022 May 2;4:ojac036. doi: 10.1093/asjof/ojac036. eCollection 2022.
7
Microbiology of breast tissue expanders.乳房组织扩张器的微生物学
Contemp Oncol (Pozn). 2021;25(4):291-294. doi: 10.5114/wo.2021.112561. Epub 2022 Jan 5.
8
In Vitro Evaluation of Common Antimicrobial Solutions Used for Breast Implant Soaking and Breast Pocket Irrigation-Part 2: Efficacy Against Biofilm-Associated Bacteria.体外评估用于乳房植入物浸泡和乳房口袋灌洗的常见抗菌溶液 - 第 2 部分:针对生物膜相关细菌的功效。
Aesthet Surg J. 2021 Oct 15;41(11):1252-1262. doi: 10.1093/asj/sjaa308.
9
In Vitro Evaluation of Common Antimicrobial Solutions Used for Breast Implant Soaking and Breast Pocket Irrigation-Part 1: Efficacy Against Planktonic Bacteria.体外评估用于乳房植入物浸泡和乳房口袋灌洗的常见抗菌溶液 - 第 1 部分:对浮游菌的功效。
Aesthet Surg J. 2021 Oct 15;41(11):1242-1251. doi: 10.1093/asj/sjaa309.
10
Safety and Efficacy of Smooth Surface Tissue Expander Breast Reconstruction.光滑表面组织扩张器乳房重建的安全性和有效性。
Aesthet Surg J. 2020 Jan 1;40(1):53-62. doi: 10.1093/asj/sjy199.